What is Lumiata?
Headquartered in San Mateo, California, Lumiata operates at the intersection of data science and clinical medicine. The company provides a sophisticated database platform that integrates millions of patient records with advanced clinical, risk, and financial algorithms. By offering pre-trained models and analytic tools, Lumiata enables healthcare organizations to optimize cost management and improve patient outcomes through data-driven insights. Its position in Silicon Valley allows it to tap into a robust ecosystem of innovation, ensuring its predictive capabilities remain at the forefront of the industry.
How much funding has Lumiata raised?
Lumiata has raised a total of $22.4M across 4 funding rounds:
Series A
$5M
Debt
$3M
Debt
$350K
Series B
$14M
Series A (2014): $5M with participation from Sandbox Industries, BlueCross BlueShield Venture Partners, L.P., and AmeriHealth
Debt (2017): $3M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Series B (2021): $14M featuring Defy.vc, AllegisNL Capital, Khosla Ventures, and The Blue Venture Fund
Key Investors in Lumiata
Khosla Ventures
A prominent venture capital firm founded by Vinod Khosla, specializing in breakthrough technologies across sectors including AI, health, and enterprise software.
BlueCross BlueShield Venture Partners, L.P.
A strategic investment arm that manages capital to support emerging companies relevant to Blue Cross and Blue Shield plans, focusing on healthcare innovation.
Sandbox Industries
A venture capital firm that bridges the gap between entrepreneurial startups and large corporate enterprises, with a strong focus on the healthcare and food sectors.
What's next for Lumiata?
Looking ahead, Lumiata is well-positioned to capitalize on the increasing demand for AI-driven healthcare solutions. The recent capital influx is expected to accelerate the development of its core platform, potentially expanding its suite of predictive tools to address emerging challenges in population health management and value-based care. As the company continues to refine its algorithms, it remains a critical partner for large-scale healthcare enterprises seeking to mitigate financial risk and enhance operational efficiency through high-fidelity data analytics.
See full Lumiata company page
